Nationwide Fund Advisors - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 80 filers reported holding REPROS THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q1 2015$151,000
-16.6%
17,611
-3.1%
0.00%0.0%
Q4 2014$181,000
+1.7%
18,176
+1.1%
0.00%0.0%
Q3 2014$178,000
-42.4%
17,985
+0.8%
0.00%0.0%
Q2 2014$309,000
-1.6%
17,844
+0.9%
0.00%0.0%
Q1 2014$314,000
-3.1%
17,6810.0%0.00%0.0%
Q4 2013$324,000
-33.7%
17,681
-3.2%
0.00%
-50.0%
Q3 2013$489,000
+87.4%
18,264
+29.1%
0.00%
+100.0%
Q2 2013$261,00014,1520.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$9,727,0002.05%
RTW INVESTMENTS, LP 229,364$1,970,0000.89%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 361,300$3,104,0000.85%
DESTRIER CAPITAL MANAGEMENT LLC 329,030$2,826,0000.73%
SENZAR ASSET MANAGEMENT, LLC 244,006$2,096,0000.51%
GENERAL AMERICAN INVESTORS CO INC 508,375$4,367,0000.36%
CQS Cayman LP 700,000$6,013,0000.28%
Rotella Capital Management, Inc. 20,800$179,0000.15%
Baker Brothers Advisors 2,000,000$17,180,0000.14%
Gruss Capital Management LP 304,000$2,611,0000.11%
View complete list of REPROS THERAPEUTICS INC shareholders